Issue 20, 2021

IR780-based nanomaterials for cancer imaging and therapy

Abstract

IR780, a small molecule with a strong optical property and excellent photoconversion efficiency following near infrared (NIR) irradiation, has attracted increasing attention in the field of cancer treatment and imaging. This review is focused on different IR780-based nanoplatforms and the application of IR780-based nanomaterials for cancer bioimaging and therapy. Thus, this review summarizes the overall aspects of IR780-based nanomaterials that positively impact cancer biomedical applications.

Graphical abstract: IR780-based nanomaterials for cancer imaging and therapy

Article information

Article type
Review Article
Submitted
26 Feb 2021
Accepted
09 Apr 2021
First published
09 Apr 2021

J. Mater. Chem. B, 2021,9, 4079-4097

IR780-based nanomaterials for cancer imaging and therapy

L. Wang and C. Niu, J. Mater. Chem. B, 2021, 9, 4079 DOI: 10.1039/D1TB00407G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements